Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 3
Featured
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
PT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study
MindMed Board of Directors Approves Reverse Share Split
COMPASS Pathways plc announces second quarter 2022 financial results and business...
MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Canadian Patent Grant Strengthens Small Pharma’s International Position
Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...
Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A
Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin
PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...
COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...
1
2
3
4
...
150
Page 3 of 150